At the annual meeting of the American Society of Oncology (ASCO) held in Chicago in 2023, Chinese pharmaceutical enterprises submitted 44 abstracts that referred to solid tumors. Non-small cell lung cancer (NSCLC) was another topic that was addressed by a larger number of the submitted papers.
Number of clinical research papers submitted by Chinese pharmaceutical enterprises at ASCO 2023, by addressed disease
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Revenue of Syneos Health 2013-2022
- Basic Statistic SG&A expenses of Syneos Health 2013-2022
- Basic Statistic Net income of Syneos Health 2013-2022
- Basic Statistic Capital expenditures of Syneos Health 2013-2022
- Premium Statistic Revenue of Syneos Health 2015-2022, by segment
- Basic Statistic Number of employees at Syneos Health 2014-2022
- Basic Statistic Rate of return on biopharma R&D late stage pipeline 2013-2022
- Basic Statistic Top 50 global pharmaceutical and biotech companies by R&D intensity in 2022
- Basic Statistic Global top pharmaceutical companies based on R&D spending 2026
- Basic Statistic Leading COVID-19 drugs, therapies and vaccines in development by early results 2020
About the region
10
- Premium Statistic Distribution of Sino Biopharm revenue 2022, by product category
- Premium Statistic Market size of biopharmaceuticals in China 2013-20225
- Premium Statistic Market size of branded biopharmaceuticals in China 2013-2023
- Premium Statistic Sino Biopharm annual revenue 2013-2022
- Premium Statistic Sino Biopharm net profit 2013-2022
- Premium Statistic Market distribution of diabetic drug products in China 2021
- Premium Statistic Sales distribution of diabetic drugs in China 2020, by category
- Premium Statistic Leading suppliers of China's human vaccines 2021, based on import value share
- Premium Statistic Vaccine release volume in China 2008-2021
- Premium Statistic Market size of diabetes medication sector in China 2016-2022
Other regions
9
- Basic Statistic Revenue of Grifols 2014-2022
- Basic Statistic Annual profit/loss of Sobi 2009-2023
- Premium Statistic Projection of top 2024 pharma and biotech launches by revenue 2028
- Premium Statistic Sales revenue Yuhan 2015-2023
- Premium Statistic Biopharmaceuticals market value in Latin America 2022-2027
- Premium Statistic Market value of pharmaceutical market in Vietnam 2012-2017
- Premium Statistic Leading orphan designations in the EU by indication 2015
- Basic Statistic Share of total business expenditure on technology R&D in Australia 2014
- Basic Statistic Pharmaceutical revenue as percent of health spending in African major countries 2014
Related statistics
8
- Premium Statistic Patent applications filed by high-tech companies in China, by industry 2022
- Premium Statistic Valid invention patents owned by high-tech companies in China 2021, by industry
- Premium Statistic High-tech industry R&D spending in China 2022
- Premium Statistic Expenditure of high-tech companies on product development 2021, by sector
- Premium Statistic Revenue generated by high-tech companies through new products 2021, by industry
- Premium Statistic High-tech companies research and development (R&D) projects in China 2022
- Premium Statistic New products developed by high-tech companies in China 2022, by industry
- Premium Statistic Profit to cost ratio of industrial enterprises China 2012, by industry
Further related statistics
10
- Sanofi's total assets 2007-2023
- Merck & Co - expenditure on research and development 2006-2023
- Key figures on established biotech centers worldwide 2012-2016
- Merck & Co cash dividends declared 2006-2023
- Merck & Co total assets 2009-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- AstraZeneca's expenditure on research and development 2006-2023
- GSK's operating profit by division 2006-2021
- Medicinal market growth worldwide including rebates 2009-2018
- Expenditure worldwide on diabetes by market 2013-2018
Further Content: You might find this interesting as well
Statistics
- Sanofi's total assets 2007-2023
- Merck & Co - expenditure on research and development 2006-2023
- Key figures on established biotech centers worldwide 2012-2016
- Merck & Co cash dividends declared 2006-2023
- Merck & Co total assets 2009-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- AstraZeneca's expenditure on research and development 2006-2023
- GSK's operating profit by division 2006-2021
- Medicinal market growth worldwide including rebates 2009-2018
- Expenditure worldwide on diabetes by market 2013-2018
DXY.cn. (June 19, 2023). Number of clinical research papers submitted by Chinese pharmaceutical enterprises at ASCO 2023, by addressed disease [Graph]. In Statista. Retrieved May 17, 2024, from https://www.statista.com/statistics/1398481/papers-of-chinese-companies-at-asco-by-disease/
DXY.cn. "Number of clinical research papers submitted by Chinese pharmaceutical enterprises at ASCO 2023, by addressed disease." Chart. June 19, 2023. Statista. Accessed May 17, 2024. https://www.statista.com/statistics/1398481/papers-of-chinese-companies-at-asco-by-disease/
DXY.cn. (2023). Number of clinical research papers submitted by Chinese pharmaceutical enterprises at ASCO 2023, by addressed disease. Statista. Statista Inc.. Accessed: May 17, 2024. https://www.statista.com/statistics/1398481/papers-of-chinese-companies-at-asco-by-disease/
DXY.cn. "Number of Clinical Research Papers Submitted by Chinese Pharmaceutical Enterprises at Asco 2023, by Addressed Disease." Statista, Statista Inc., 19 Jun 2023, https://www.statista.com/statistics/1398481/papers-of-chinese-companies-at-asco-by-disease/
DXY.cn, Number of clinical research papers submitted by Chinese pharmaceutical enterprises at ASCO 2023, by addressed disease Statista, https://www.statista.com/statistics/1398481/papers-of-chinese-companies-at-asco-by-disease/ (last visited May 17, 2024)
Number of clinical research papers submitted by Chinese pharmaceutical enterprises at ASCO 2023, by addressed disease [Graph], DXY.cn, June 19, 2023. [Online]. Available: https://www.statista.com/statistics/1398481/papers-of-chinese-companies-at-asco-by-disease/